US Stock Insider Trading | Ardelyx discloses 25 insider transactions on February 23

K-LinePoet · 2026-02-27T11:06:42+00:00

On February 23, 2026, Ardelyx reported multiple insider transactions, including Director MOTT DAVID M purchasing 333,300 shares on February 20. Additionally, Director RAAB MICHAEL and executive Kelliher Mike also conducted sell transactions. Ardelyx is a clinical-stage biopharmaceutical company focused on the development of innovative drugs for gastrointestinal and metabolic diseases.

K-LinePoet

2026-02-27 11:06:42

Abstract generation in progress

On February 23, 2026, Ardelyx (ARDX) disclosed 25 insider trading transactions. Director MOTT DAVID M purchased 333,300 shares on February 20, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 23, 2026	Director	RAAB MICHAEL	February 20, 2026	Sell	5,576	5.71	$31,900
February 23, 2026	Executive	Kelliher Mike	February 20, 2026	Sell	1,159	5.71	$6,622.29
February 23, 2026	Director	RAAB MICHAEL	February 20, 2026	Sell	2	5.70	$11.40
February 23, 2026	Director	RAAB MICHAEL	February 20, 2026	Sell	1	5.70	$5.70
February 23, 2026	Director	RAAB MICHAEL	February 20, 2026	Sell	40,400	5.87	$237,000
February 23, 2026	Executive	Kelliher Mike	February 20, 2026	Sell	2	5.71	$11.41
February 23, 2026	Director	MOTT DAVID M	February 20, 2026	Buy	333,300	5.84	$1,946,300
February 23, 2026	Director	RAAB MICHAEL	February 20, 2026	Sell	2	5.70	$11.40
February 23, 2026	Executive	Foster Eric Duane	February 20, 2026	Sell	1	5.70	$5.70
February 23, 2026	Executive	Kelliher Mike	February 20, 2026	Sell	8,434	5.87	$49,500

【Company Information】

Ardelyx, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and commercializing innovative, non-systemic small molecule therapies, primarily targeting gastrointestinal, cardiometabolic, and renal diseases. The company’s drug discovery and design platform enables it to identify and develop new candidate drugs quickly and cost-effectively. Founded on October 17, 2007, in Delaware, the company was renamed Ardelyx in June 2008.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.